Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Actinium Pharmaceuticals Inc (ATNM)

Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 220,096
  • Shares Outstanding, K 29,783
  • Annual Sales, $ 80 K
  • Annual Income, $ -48,820 K
  • 60-Month Beta 0.12
  • Price/Sales 2,709.89
  • Price/Cash Flow N/A
  • Price/Book 4.86
Trade ATNM with:

Options Overview Details

View History
  • Implied Volatility 55.35% ( -25.16%)
  • Historical Volatility 45.76%
  • IV Percentile 2%
  • IV Rank 7.94%
  • IV High 167.63% on 01/18/24
  • IV Low 45.66% on 09/27/23
  • Put/Call Vol Ratio 0.97
  • Today's Volume 120
  • Volume Avg (30-Day) 190
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 6,229
  • Open Int (30-Day) 6,034

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.48
  • Number of Estimates 2
  • High Estimate -0.38
  • Low Estimate -0.58
  • Prior Year -0.58
  • Growth Rate Est. (year over year) +17.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.00 +5.71%
on 06/26/24
8.58 -13.75%
on 06/05/24
-0.82 (-9.98%)
since 05/28/24
3-Month
6.47 +14.37%
on 04/25/24
10.24 -27.73%
on 05/14/24
-0.43 (-5.49%)
since 03/28/24
52-Week
4.00 +85.00%
on 11/28/23
10.24 -27.73%
on 05/14/24
+0.04 (+0.54%)
since 06/28/23

Most Recent Stories

More News
Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 18, 2024) - Investorideas.com, a go-to investing platform covering biotech and medical technology stocks releases the second of a...

ATNM : 7.40 (+0.14%)
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase

EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:BPTH),(NASDAQ:LGVN),(NASDAQ:SLS),(NYSE:BMY) EQNX::TICKER_END

ATNM : 7.40 (+0.14%)
BPTH : 2.0000 (+2.56%)
LGVN : 1.6100 (-4.17%)
SLS : 1.1900 (+4.39%)
BMY : 41.53 (+0.05%)
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase

ATNM : 7.40 (+0.14%)
BPTH : 2.0000 (+2.56%)
LGVN : 1.6100 (-4.17%)
SLS : 1.1900 (+4.39%)
BMY : 41.53 (+0.05%)
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies

EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:SNDX),(NASDAQ:KURA),(NASDAQ:BMEA),(NYSE:JNJ) EQNX::TICKER_END

SNDX : 20.53 (+1.03%)
ATNM : 7.40 (+0.14%)
KURA : 20.59 (+0.44%)
BMEA : 4.50 (-0.66%)
JNJ : 146.16 (+0.25%)
Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking Therapies

SNDX : 20.53 (+1.03%)
ATNM : 7.40 (+0.14%)
KURA : 20.59 (+0.44%)
BMEA : 4.50 (-0.66%)
JNJ : 146.16 (+0.25%)
Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia (AML)

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 17, 2024) - Investorideas.com, a go-to investing platform, releases the first of a two-part series looking at developments for the...

ATNM : 7.40 (+0.14%)
Actinium Presents First Ever Data Demonstrating Statistically Significant Anti-Tumor Control and Potent Leukemic Cell Killing with Actimab-A in Combination with Leading Menin Inhibitors in Preclinical Acute Myeloid Leukemia Models at the 2024 EHA Congress

Actimab-A enhances dose-dependent acute myeloid leukemia cell death in KMT2A sensitive acute myeloid leukemia blasts in combination with leading menin inhibitors Combination with leading menin inhibitor...

ATNM : 7.40 (+0.14%)
Actinium Pharma Highlights Three Abstracts Accepted for Poster Presentation at the SOHO 2023 Annual Meeting

/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today...

ATNM : 7.40 (+0.14%)
Actinium Pharma Highlights Six Abstracts Accepted for Oral and Poster Presentation at the SNMMI 2023 Annual Meeting

/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today...

ATNM : 7.40 (+0.14%)
Actinium Pharma to Present at the Maxim Healthcare Virtual Conference

/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today...

ATNM : 7.40 (+0.14%)

Business Summary

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing ARCs or Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. Actinium's lead application for their ARCs is targeted conditioning, which is intended...

See More

Key Turning Points

3rd Resistance Point 8.00
2nd Resistance Point 7.73
1st Resistance Point 7.56
Last Price 7.40
1st Support Level 7.12
2nd Support Level 6.85
3rd Support Level 6.68

See More

52-Week High 10.24
Fibonacci 61.8% 7.86
Last Price 7.40
Fibonacci 50% 7.12
Fibonacci 38.2% 6.38
52-Week Low 4.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar